SpringBig S-1 Reveals Massive Dilution Risk from Selling Shareholder Resales

Ticker: SBIGW · Form: S-1 · Filed: Sep 2, 2025 · CIK: 1801602

Springbig Holdings, Inc. S-1 Filing Summary
FieldDetail
CompanySpringbig Holdings, Inc. (SBIGW)
Form TypeS-1
Filed DateSep 2, 2025
Risk Levelhigh
Pages14
Reading Time17 min
Key Dollar Amounts$0.0001, $10.00, $25,000, $0.00625, $1.00
Sentimentbearish

Sentiment: bearish

Topics: S-1 Filing, Dilution Risk, Warrants, Convertible Notes, Selling Shareholders, Cannabis Technology, OTC Markets

Related Tickers: SBIGW

TL;DR

**SBIGW is a dilution disaster waiting to happen; stay far away as insiders dump cheap shares into a collapsing stock.**

AI Summary

SpringBig Holdings, Inc. (SBIGW) filed an S-1 on August 29, 2025, primarily for the registration of a substantial number of securities for resale by selling securityholders, rather than a primary offering by the company. The filing indicates that up to 16,000,000 shares of Common Stock are issuable upon the exercise of public and private warrants, with an exercise price of $11.50 per warrant. Additionally, up to 21,590,291 shares of Common Stock are being offered for sale by various selling securityholders, including 1,310,000 PIPE shares and 4,000,000 Founder Shares. A significant 51,414,012 shares of Common Stock are reserved for issuance upon the conversion of Senior Secured Convertible Promissory Notes due 2027, which were issued for $6,400,000 in total cash consideration at an original conversion price of $0.15 per share. The company will not receive proceeds from the sale of shares by selling securityholders, except from warrant exercises, which are unlikely given the August 28, 2025 closing price of $0.033, significantly below the $11.50 exercise price. The total shares registered for potential resale represent approximately 197% of the company's outstanding shares as of July 22, 2025, posing a substantial dilution risk.

Why It Matters

This S-1 filing signals a significant overhang for SpringBig Holdings, Inc. investors, as the potential resale of 197% of outstanding shares could severely depress the stock price. The low current trading price of $0.033, far below the $10.00 IPO unit price and $11.50 warrant exercise price, means public investors face substantial losses, while early investors like the Sponsor could still profit from their $0.00625 per share purchase. This dynamic creates a strong incentive for selling securityholders to offload shares, exacerbating volatility and making it difficult for the stock to recover. Competitors in the cannabis tech space might see this as a sign of financial instability, potentially impacting SpringBig's market position and ability to attract new capital or customers.

Risk Assessment

Risk Level: high — The risk level is high due to the registration of 197% of outstanding shares for potential resale by selling securityholders, which could cause significant dilution and price volatility. The closing price of SBIGW was $0.033 on August 28, 2025, substantially below the $11.50 warrant exercise price, making cash proceeds from warrant exercises unlikely. Furthermore, the Sponsor and other Founder Share holders, who acquired shares at $0.00625, still stand to profit even at the current low price, creating a strong incentive for them to sell.

Analyst Insight

Investors should avoid SpringBig Holdings, Inc. (SBIGW) given the immense dilution risk and the significant incentive for selling securityholders to offload shares at prices far below the original IPO unit price. Existing shareholders should consider exiting their positions, as the substantial overhang of registered shares is likely to continue to suppress the stock price and increase volatility.

Key Numbers

  • $0.033 — Closing price of Common Stock (As of August 28, 2025, significantly below warrant exercise price.)
  • 16,000,000 — Shares underlying warrants (Total shares issuable upon exercise of public and private warrants.)
  • $11.50 — Warrant exercise price (Per warrant, making exercise unlikely given current stock price.)
  • 21,590,291 — Shares offered by selling securityholders (Includes PIPE shares, Founder Shares, and merger consideration shares.)
  • 51,414,012 — Shares underlying Convertible Notes (Reserved for issuance upon conversion of Senior Secured Convertible Promissory Notes.)
  • $0.15 — Original conversion price of Convertible Notes (Per share, for the 51,414,012 Conversion Shares.)
  • $6,400,000 — Total cash consideration for Convertible Notes (Amount received by the company for issuing Convertible Notes.)
  • 197% — Percentage of outstanding shares registered for resale (Represents a massive potential dilution relative to shares outstanding as of July 22, 2025.)
  • $0.00625 — Founder Shares purchase price (Per share, providing a significant profit incentive for the Sponsor even at current low prices.)
  • $10.00 — PIPE shares purchase price (Per share, for 1,310,000 PIPE Investors.)

Key Players & Entities

  • SpringBig Holdings, Inc. (company) — Registrant and issuer of securities
  • Tuatara Capital Acquisition Corporation (company) — Predecessor of SpringBig Holdings, Inc.
  • Jaret Christopher (person) — Chief Executive Officer and Chairman of SpringBig Holdings, Inc., also a seller in VICE CRM acquisition
  • TCAC Sponsor, LLC (company) — Sponsor and holder of Founder Shares and private placement warrants
  • VICE CRM, LLC (company) — Company acquired by SpringBig Holdings, Inc.
  • Benesch, Friedlander, Coplan & Aronoff LLP (company) — Legal counsel for the registrant
  • Aslam A. Rawoof (person) — Legal counsel from Benesch, Friedlander, Coplan & Aronoff LLP
  • Securities and Exchange Commission (regulator) — Regulatory body for S-1 filing
  • Yuzz Buzz, LLC (company) — Party to the Settlement Agreement
  • Continental Stock Transfer & Trust Company (company) — Transfer agent for SpringBig Holdings, Inc.

FAQ

What is the primary purpose of SpringBig Holdings, Inc.'s S-1 filing?

The primary purpose of SpringBig Holdings, Inc.'s S-1 filing is to register a substantial number of securities for resale by various selling securityholders, including shares underlying warrants and convertible notes, rather than to raise new capital for the company through a primary offering.

How many shares are registered for potential resale by SpringBig's selling securityholders?

The S-1 filing indicates that up to 21,590,291 shares of Common Stock are being offered for sale by selling securityholders, in addition to 16,000,000 shares underlying warrants and 51,414,012 shares underlying convertible notes, totaling approximately 197% of the company's outstanding shares as of July 22, 2025.

Will SpringBig Holdings, Inc. receive proceeds from the sale of these registered securities?

SpringBig Holdings, Inc. will not receive any proceeds from the sale of shares by the Selling Securityholders, except for amounts received upon the exercise of warrants for cash. However, the likelihood of warrant exercise is low given the $0.033 stock price versus the $11.50 exercise price.

What is the exercise price for SpringBig's public and private warrants?

The exercise price for both SpringBig Holdings, Inc.'s public warrants and private placement warrants is $11.50 per warrant. This is significantly higher than the closing price of $0.033 on August 28, 2025.

What is the potential profit incentive for the Sponsor and Founder Share holders of SpringBig?

The Sponsor and other holders of Founder Shares purchased their shares at an initial aggregate price of $0.00625 per share. Based on the August 28, 2025 closing price of $0.033, they would experience a potential profit of approximately $0.023 per share, or up to approximately $0.1 million in aggregate, providing a strong incentive to sell.

What is the impact of the large number of registered shares on SpringBig's stock price?

The registration of approximately 197% of SpringBig's outstanding shares for potential resale creates a significant overhang, which could increase the volatility of the market price of the Common Stock or result in a substantial decline in its public trading price due to potential dilution.

What was the original conversion price for SpringBig's Senior Secured Convertible Promissory Notes?

The original conversion price for SpringBig Holdings, Inc.'s Senior Secured Convertible Promissory Notes due 2027 is $0.15 per share, for which up to 51,414,012 shares of Common Stock are reserved for issuance.

When did SpringBig Holdings, Inc. begin trading on the OTCQB Market?

SpringBig Holdings, Inc.'s Common Stock began trading on the OTCQB Market under the symbol 'SBIG' on April 1, 2025.

What was the business combination that led to SpringBig Holdings, Inc.?

On June 14, 2022, Tuatara Capital Acquisition Corporation consummated a business combination with SpringBig, Inc. (Legacy SpringBig), after which Tuatara changed its name to SpringBig Holdings, Inc. and Legacy SpringBig became a subsidiary.

What is SpringBig Holdings, Inc.'s status as an 'emerging growth company'?

SpringBig Holdings, Inc. is an 'emerging growth company' under federal securities laws, which means it is subject to reduced public company reporting requirements.

Risk Factors

  • Substantial Dilution from Resale of Securities [high — financial]: The S-1 filing registers up to 16,000,000 shares from warrants, 21,590,291 shares from selling securityholders, and 51,414,012 shares from convertible notes. This totals 89,004,303 shares, representing approximately 197% of the company's outstanding shares as of July 22, 2025, posing a significant risk of dilution to existing shareholders.
  • Unlikely Warrant Exercise [medium — financial]: The public and private warrants have an exercise price of $11.50 per share. Given the closing price of Common Stock was $0.033 on August 28, 2025, it is highly improbable that these warrants will be exercised, meaning the company is unlikely to receive proceeds from this source.
  • Convertible Note Conversion Terms [medium — financial]: 51,414,012 shares are reserved for conversion of Senior Secured Convertible Promissory Notes. These notes were issued for $6,400,000 in cash consideration at an original conversion price of $0.15 per share. While this provided capital, the conversion price is significantly lower than the initial warrant exercise price.
  • Founder Share Profitability [medium — financial]: Founder Shares were acquired at a purchase price of $0.00625 per share. Even with the current low stock price of $0.033, this represents a substantial profit margin for the founders, potentially influencing their decisions regarding share sales.
  • PIPE Investor Purchase Price [medium — financial]: 1,310,000 PIPE shares were purchased at $10.00 per share. This price is substantially higher than the current market price, indicating potential losses for these investors and possible pressure on the company.

Industry Context

SpringBig operates in the cannabis technology sector, providing software solutions for dispensaries and brands. This industry is characterized by rapid growth, evolving regulatory landscapes across different jurisdictions (e.g., Canada's Cannabis Act, U.S. Controlled Substances Act), and increasing competition from both specialized tech providers and larger enterprise software companies looking to enter the niche market.

Regulatory Implications

The company's operations are subject to various regulations, including those related to cannabis (e.g., Canadian CRTC, U.S. CSA) and telecommunications. Compliance with these evolving rules is critical, and any changes or enforcement actions could materially impact the business. The S-1 itself is a regulatory filing required for the resale of securities.

What Investors Should Do

  1. Monitor share price relative to warrant exercise price ($11.50) and convertible note conversion price ($0.15).
  2. Assess the impact of the 197% potential dilution from registered shares.
  3. Evaluate the profitability of selling securityholders, particularly founders and PIPE investors.
  4. Scrutinize any future financial disclosures for revenue and profitability trends.

Key Dates

  • 2025-08-29: S-1 Filing — Registration of securities for resale by selling securityholders, indicating potential significant dilution.
  • 2025-08-28: Common Stock Closing Price — $0.033, significantly below warrant exercise price, making exercise unlikely.
  • 2025-07-22: Outstanding Shares Record Date — Used to calculate the 197% dilution from registered shares.
  • 2027: Convertible Notes Due — Maturity date for Senior Secured Convertible Promissory Notes, potentially leading to conversion or repayment.
  • 2022-04-14: Amended and Restated Merger Agreement — Governs the business combination that formed the current SpringBig Holdings, Inc.

Glossary

Selling Securityholders
Individuals or entities who own securities and are offering them for sale, as registered in the S-1 filing. (A large number of shares are being offered by these holders, indicating potential significant selling pressure on the stock.)
Warrants
Financial instruments that give the holder the right, but not the obligation, to buy a company's stock at a specified price (exercise price) before a certain expiration date. (The S-1 registers shares underlying warrants with a high exercise price ($11.50), making their exercise unlikely at the current stock price ($0.033).)
PIPE Shares
Private Investment in Public Equity. Shares sold privately to institutional investors, often at a discount to market price. (1,310,000 PIPE shares are registered for resale, purchased at $10.00 per share, which is significantly above the current market price.)
Founder Shares
Shares typically issued to the founders of a company, often at a nominal price, before going public. (4,000,000 Founder Shares are registered for resale, acquired at $0.00625 per share, offering substantial profit potential.)
Senior Secured Convertible Promissory Notes
Debt instruments that can be converted into equity (Common Stock) under certain conditions, with a senior secured status and a maturity date. (51,414,012 shares are reserved for conversion of these notes, which were issued for $6,400,000 at an original conversion price of $0.15 per share.)
Dilution
The reduction in the value of existing shareholders' equity resulting from the issuance of new shares. (The S-1 registers a massive number of shares for resale (197% of outstanding shares), posing a severe dilution risk.)
S-1 Filing
A registration statement filed with the U.S. Securities and Exchange Commission (SEC) by companies planning to offer securities to the public. (This filing details the securities being registered for resale and the potential impact on the company's capital structure and share count.)

Year-Over-Year Comparison

This S-1 filing is primarily for the resale of securities by existing holders, rather than a primary offering. Therefore, direct year-over-year comparisons of key financial metrics like revenue growth, margins, or net income are not possible from this document alone. The focus is on the potential dilution and the terms of existing debt and equity instruments, which have likely evolved since any previous filings.

Filing Stats: 4,300 words · 17 min read · ~14 pages · Grade level 18.2 · Accepted 2025-08-29 21:30:16

Key Financial Figures

  • $0.0001 — 0,000 shares of Common Stock, par value $0.0001 per share (the “Common Stock&rdqu
  • $10.00 — a (the “IPO”) at a price of $10.00 per unit, with each unit consisting of
  • $25,000 — an initial aggregate purchase price of $25,000, or $0.00625 per share, in a private pl
  • $0.00625 — aggregate purchase price of $25,000, or $0.00625 per share, in a private placement in co
  • $1.00 — purchased by the Sponsor at a price of $1.00 per warrant, or $6,000,000 in the aggre
  • $6,000,000 — sor at a price of $1.00 per warrant, or $6,000,000 in the aggregate, (D) up to 1,700,000 s
  • $6,400,000 — vertible Notes Selling Stockholders for $6,400,000 in total cash consideration. The Conver
  • $0.15 — able at an original conversion price of $0.15 per share. We are not selling any of th
  • $10 — ur trading price is significantly below $10.00, the offering price for the units of
  • $0.033 — he closing price of our common stock of $0.033 as of August 28, 2025, the Sponsor and
  • $0.023 — potential profit of up to approximately $0.023 per share, or up to approximately $0.1
  • $0.1 million — 0.023 per share, or up to approximately $0.1 million in the aggregate. We will not receive
  • $11.50 — rants and private placement warrants is $11.50 per warrant. We believe the likelihood
  • $13,100,000 — n financing” are to the aggregate $13,100,000 of proceeds from the issuance of the su
  • $ — ecessor entity to SpringBig and “$,” “US
    amp;rdquo; and “U.

Filing Documents

Use of Proceeds

Use of Proceeds 11 Determination of Offering Price 11 Market Information for Common Stock and Dividend Policy 11

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 12 Selling Stockholders 14 Certain U.S. Federal Income Tax Considerations 18 Plan of Distribution 24 Legal Matters 28 Experts 28 Where You Can Find More Information 28 Information Incorporated by Reference 29 i FREQUENTLY USED TERMS As used in this document, references to: “amended and restated merger agreement” are to the amended and restated agreement and plan of merger, dated as of April 14, 2022, by and among Tuatara, Merger Sub and Legacy SpringBig, as amended by Amendment No. 1, dated as of May 7, 2022; “amended and restated registration rights agreement” are to the Amended and Restated Registration Rights Agreement entered into, by and among Tuatara, Sponsor, Legacy SpringBig, and the other signatories thereto; “business combination” are to the transactions contemplated by the merger agreement “Canadian CRTC” are to the Canadian Radio-Television and Telecommunications Commission; “Cannabis Act” are to the Cannabis Act (Canada); “Code” are to the Internal Revenue Code of 1986, as amended “Common Shares,” “Common Stock” or “Shares” are to the shares of common stock of SpringBig Holdings, Inc., par value $0.0001 per share “Company,” “SpringBig,” “we,” “us,” “our” and similar terms are to SpringBig Holdings, Inc., a Delaware corporation, and its consolidated subsidiaries; “COVID-19” are to SARS-Cov-2 or COVID-19, and any evolutions thereof or related or associated epidemics, pandemics or disease outbreaks; “CSA” are to the U.S. Controlled Substances Act of 1970, as amended; “DGCL” are to the Delaware General Corporation Law, as amended; “effective time” are to the effective time of the certificate of merger effecting the merger contemplated by

View Full Filing

View this S-1 filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.